Login / Signup
Low-dose IL-2 may enhance the effect of vedolizumab.
Cheng Hiang Lee
Sarah Huang
Peter Hsu
Rupert W L Leong
Brigitte Nanan
Ralph Nanan
Published in:
Scandinavian journal of gastroenterology (2022)
Keyphrases
</>
low dose
ulcerative colitis
patients with inflammatory bowel disease
high dose